Anna Schöllhorn
6PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 07, 2025
Vaccination Against RhoC in Prostate Cancer Patients Induces Potent and Long-Lasting CD4+ T Cell Responses with Cytolytic Potential in the Absence of Clinical Efficacy: A Randomized Phase II Trial.Sara Fresnillo Saló, Juliane Schuhmacher, Anne Rahbech
|Dec 08, 2022
CAF-immune cell crosstalk and its impact in immunotherapy.Ana Maia, Anna Schöllhorn, Juliane Schuhmacher
|Feb 08, 2022
Integrin activation enables rapid detection of functional Vδ1+ and Vδ2+ γδ T cells.Nicola Herold, Anna Schöllhorn, Adrian Feile
|Apr 28, 2021
Common virulence gene expression in adult first-time infected malaria patients and severe cases.J Stephan Wichers, Gerry Tonkin-Hill, Thorsten Thye
|Feb 06, 2021
CD4+ T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy.Jennifer R Richardson, Anna Schöllhorn, Cécile Gouttefangeas
|Feb 03, 2019
Cyanobacterial antimetabolite 7-deoxy-sedoheptulose blocks the shikimate pathway to inhibit the growth of prototrophic organisms.Klaus Brilisauer, Johanna Rapp, Pascal Rath
Pageof 1
Frequent Collaborators
4 joint publications
Cécile Gouttefangeas
2 joint publications
Juliane Schuhmacher
1 joint publications
Klaus Brilisauer
1 joint publications
Johanna Rapp
1 joint publications
Karl Forchhammer
1 joint publications
Jennifer R Richardson
1 joint publications
J Stephan Wichers
1 joint publications
Gerry Tonkin-Hill
1 joint publications
Thorsten Thye
1 joint publications
Ralf Krumkamp
